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Relationship of Anger Trait and Anger Expression to                         
C-Reactive Protein in Post-Menopausal Women  
 
Rosalyn Gross 
 
ABSTRACT 
 
Coronary heart disease is the leading cause of death in American 
women, accounting for one in six deaths in 2004. One third of women 
over the age of forty will develop coronary heart disease in their 
lifetime. The role of chronic and excessive inflammation and risk 
factors, such as smoking and high cholesterol, are now well-
established factors contributing to coronary heart disease pathology. A 
knowledge gap exists in that little is known about the mechanisms by 
which psychosocial factors, such as anger, may be associated with 
pro-inflammatory processes that contribute to cardiovascular morbidity 
and mortality in women. The purpose of this study was to determine if 
there were differences in serum levels of the proinflammatory 
biomarker, C-reactive protein, in post-menopausal women who scored 
high on anger characteristics compared to those with low anger  
characteristics. Mean levels of C-reactive protein were not found to be 
different in a sample of 42 women with high trait anger or high anger  
expression compared to those with low trait anger or low anger 
expression. Significant relationships were found in C-reactive protein 
vi 
 
and some anger control characteristics (anger control-in) and might 
imply that certain anger expression styles may play a role in pro-
inflammatory responses in post-menopausal women. 
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Chapter One:  Introduction to the Study 
 
 
Statement of the Problem 
Cardiovascular disease is the leading cause of mortality in American 
women with coronary heart disease (CHD) responsible for 50% of deaths in 
2004. One third of women over the age of 40 will develop coronary heart disease 
in their lifetime (Rosamond et al., 2007).  Two-thirds of women who experience 
sudden death from CHD had no previous symptoms of their illness (Wenger, 
2004). Chronic and excessive inflammation and risk factors such as smoking and 
hypercholesterolemia, are now well-established factors contributing to CHD 
pathology. However, little is known about the mechanisms by which psychosocial 
factors, such as anger, may be associated with proinflammatory processes that 
play a role in cardiovascular morbidity and mortality in women.  
Background and Significance 
 Anger is a universal powerful and generally negative emotion that is 
expressed throughout the lifespan and is associated with enhanced vascular 
tone, elevated heart rate, and elevated blood pressure responses, similar to 
those elicited by the fear response (Bongard, Pfeiffer, Al-Absi, Hodapp, & 
Linnenekember, 1997).  Anger has been associated with angina, myocardial 
infarction, and sudden cardiac death (Kop, 1999; Stuart-Shor, Buselli, & Carroll, 
2003) as a result of direct acute and indirect chronic biological processes. These 
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include cardiovascular reactivity (CVR), which is an increased heart rate and 
blood pressure in response to stress, stress-induced hypertension (Abel, Larkin, 
& Edins, 1995), carotid atherosclerosis (Matthews, Owens, Kuller, Sutton-Tyrrell, 
& Jansen-McWilliams, 1998; Troxel, Matthews, Bromberger, & Sutton-Tyrell, 
2003), existing CHD, (Linfante, Allan, Smith, & Mosca, 2003), incident heart 
disease (Gallacher, Yarnell, Sweetnam, Elwood, & Stansfeld, 1999), and 
metabolic syndrome (Raikkonen, Matthews, & Kuller, 2001).  
 Current theories regarding mechanisms for the potential relationship of 
CHD to dysphoric emotional states and traits, such as anger, date back to the 
early 20th century and are based on the association of a recurrent pattern of an 
exaggerated sympathetic nervous system response. Alexander (1939) first 
proposed that anger contributed to the development of sustained elevated blood 
pressure because of chronic activation of the autonomic and cardiovascular 
systems. Alexander’s theory led to the identification by Dunbar (1943) of the 
“coronary prone personality” that subsequently formed the now famous 
designation of the Type A behavior pattern and especially the harmful anger-
hostility personality component (Spielberger et al., 1985). Research investigating 
anger, specifically trait anger (anger proneness), emerged in the 70s and 80s, 
when researchers began to explore physiological reactivity relationships and 
personality characteristics (Schum, Jorgensen, Verhaeghen, Sauro, & 
Thibodeau, 2003).  
 Many large prospective designs have examined the significant role that 
anger and hostility have on CVR and CHD. The majority of these studies suggest 
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that anger directly or indirectly predisposes individuals to heightened CVR, which 
may lead to increased risk of development of hypertension and heart disease 
(Eng, Fitzmaurice, Kubzansky, Rimm, & Kawachi, 2003; Everson, Goldberg, 
Kaplan, Julkunen, & Salonen, 1998; Everson-Rose & Lewis, 2005; Fichera  & 
Andreassi, 1998; Julkunen & Ahlstrom, 2006; Lovallo & Gerin, 2003; Swartz, 
Gerin, Davidson, Pickering, Phil, Brosschot, et al., 2003; Thomas, 1997). 
 As research continued to reveal the complex interrelationships of the 
mind-body connection and cardiovascular disease Kawachi, Sparrow, Spiro, 
Vokonas, and Weiss (1996) proposed a biopsychosocial model of anger 
interactions that promote CHD as a result of the direct biological effects of 
elevated catecholamines, increased myocardial oxygen demand, vasospasm, 
and increased platelet aggregability. Pro-inflammatory cytokines, specifically 
interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF!) 
have been identified and found to be increased in systemic inflammation and 
recognized as risk factors for poor health outcomes associated with cardiac 
disease, diabetes mellitus, and osteoporosis (Segerstrom & Miller, 2004). 
TNF! has been found to alter endothelial cell function and promote the 
expression of adhesion molecules that contribute to accumulation of cellular 
debris and also promote the production of C-reactive protein (CRP) (Suarez, 
Lewis, & Kuhn, 2002). CRP, a well-established marker for CHD risk, is an acute 
phase reactive protein that is triggered by the release of pro-inflammatory 
cytokines, particularly IL-6, and also appears to play a role in the development of 
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atherogenesis and subsequent CHD (Hapuarachchi, Chalmers, Winefield, & 
Blake-Mortimer, 2003).   
Finally, new evidence shows that chronic activation of the stress response 
with subsequent persistent release of glucocorticoid hormones and 
catecholamines, may also dysregulate immune function (Padgett & Glaser, 2003) 
including primary and secondary antibody responses (Vedhara, Fox, & Wang, 
2005). Because the effects of stressors differ over time and between individuals, 
the nature of the stressor, its contextual meaning, and host differences likely 
determine the degree to which stress reactions produce immune changes 
(Segerstrom, Kemeny, & Laudenslager, 2001). Current researchers studying 
psychoneuroimmunology (PNI) hypothesize that chronic stress and stressful 
emotions, like anger and anxiety, elicit both innate and specific immune 
responses by enhancing patterns of pro-inflammatory cytokine secretion which, 
in turn, activate the hypothalamic-hypophyseal-adrenocortical (HPA) axis and 
stimulate the acute phase response (Black, 2006; Black & Garbutt, 2002; 
Bryndon, Magid, & Steptoe, 2005; Lovallo & Gerin, 2003; Padgett & Glasser, 
2003; Segerstrom, Kemeny, & Laudenslager, 2001) and produce a variety of 
sickness behaviors, such as depression and anxiety. 
The emotion of anger is also very complex and involves cognitive, 
affective, and behavioral aspects that are biologically and culturally based (Cox, 
Stabb, & Bruckner, 1999). For women in particular, especially as a result of 
Western socialization of the female gender as less powerful, the interpersonal 
interactions of anger are intricately woven within the relationships of women’s 
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everyday lives (Thomas, Smucker, & Droppleman, 1998). The effects of 
acculturation and socialization of anger etiquette, which fosters overt displays of 
anger and aggression by men generally result in women internalizing angry 
feelings (Gilligan, 1982). As girls and boys grow up to be men and women, 
different biobehavioral patterns are developed, especially related to 
internalization and externalization of feelings. Subsequently, many women 
experience dichotomous experiences of anger, whether to suppress or express 
their thoughts and feelings (Cox et al.). 
Trait anger, a key feature of anger, describes a relatively stable 
personality trait consisting of one’s proneness to perceive situations as anger 
provoking and to respond with feelings of annoyance, irritation, or fury 
(Spielberger, Jacobs, Russell, Crane & Worden, 1985). High trait anger women 
frequently experience angry feelings, feel others treat them unfairly, and 
experience a great deal of frustration (Spielberger, 1999). Anger expression 
includes angry feelings held in or suppressed (anger-in), and angry feelings that 
are expressed (anger-out) (Spielberger et al.). High anger-in women frequently 
experience angry emotions but control the outward expression of angry feelings, 
while high anger-out women frequently express their anger by verbal or physical 
aggression towards others (Spielberger). 
Utilizing the theoretical framework proposed by Kawachi, Sparrow, Spiro, 
Vokonas, and Weiss (1996) of the mind-body anger connection to cardiovascular 
disease a conceptual model of the study is presented in Figure 1.  
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Purpose of the Study 
 The purpose of this study was to examine differences in biobehavioral 
variables in healthy post-menopausal women who were classified as high and 
low in trait anger and anger expression. The specific aims of the study were to 
compare differences in serum levels of CRP in high and low anger groups.  
The associated research questions for this study asked:   
1) Are there significant differences in mean levels of CRP in women who are 
classified as high trait anger compared to those classified as low trait anger?  
Directional hypothesis: High trait anger women will have higher mean levels of 
CRP compared to low trait anger women. 
2) Are there significant differences in mean levels of CRP in women who are 
classified as high in anger expression compared to those classified as low in 
anger expression? 
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Directional hypothesis: Women who score high on anger expression will have 
higher mean levels of CRP than those who are score low on anger expression. 
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Chapter Two:  Review of Literature 
 
The study of the relationship of psychosocial factors and reactions to 
emotional stressors such as anger, and immune dysregulation and inflammatory 
responses has emerged within the new body of research devoted to stress-
neuroendocrine-immune interactions, known as PNI (Vedhara, Fox, & Wang, 
1999). The impact of these interactions on health involves a multifaceted set of 
signals that work in bi-directional communication among the nervous, endocrine, 
and immune systems, primarily through the HPA axis and sympathetic-adrenal-
medullary axis (Padgett & Glasser, 2003). Definitions of key anger terms used for 
the review of literature are presented in Table 1, followed by a review of research 
on cardiovascular responses to anger and a review of research on inflammatory 
and immunological responses to anger. 
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Table 1. 
  
Definitions of Anger Constructs (Spielberger et al., 1985 
 
Anger An emotional state consisting of subjective feelings that vary 
in intensity from mild annoyance or irritation to intense fury 
and rage accompanied by muscular tension and arousal of 
the autonomic nervous system. 
State Anger  A psychobiological emotional state consisting of subjective 
feelings that vary in intensity from mild annoyance or 
irritation to intense fury and range accompanied by muscular 
tension and arousal of the autonomic nervous system. 
Trait Anger  Individual differences in anger proneness, i.e., the tendency 
to perceive a wide range of situations as annoying or 
frustrating, and the disposition to respond to such situations 
with elevations in state anger. 
Anger-In Individual differences in the frequency that angry feelings 
are held in or suppressed. 
Anger-Out Individual differences in the frequency that state anger is 
expressed in aggressive behavior towards other people or 
objects in the environment 
Anger-Control Individual differences in the frequency that individuals 
attempt to control the outward expression of angry feelings. 
 
Overview of Cardiovascular Responses to Anger 
Briefly, psychological or emotional stress, such as anger, causes impulses 
released from the cerebral cortex to transmit via the limbic system to nuclei in the 
hypothalamus where corticotropin-releasing factor (CRF) and arginine 
vasopressin are synthesized. CRF travels to the anterior pituitary gland that 
responds by producing adrenocorticotropic hormone (ACTH) that then stimulates 
the adrenal cortex to produce glucocorticosteroids. Glucocorticosteroids are 
permissive to the catecholamines. Arginine vasopressin also activates secretion 
of ACTH and is released by the posterior pituitary gland. Together with 
norepinephrine and epinephrine produced by the sympathetic nervous system, 
these chemicals constitute the major stress hormones which systemically 
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upregulate the cardiovascular system. Sympathetic nervous stimulation, sensed 
by the juxtaglomerular apparatus of the kidneys, affects the renin-angiotensin 
response by stimulating powerful enzymatic reactions with subsequent systemic 
vasoconstriction and increased CVR (Black & Garbutt, 2002). 
Enhanced sympathetic tone and increased CVR, often seen in acute 
anger, has been associated with an increased risk of development of CHD and 
has been correlated with increased morbidity and mortality (Abel et al., 1995; 
Shapiro, Bagiella, Myers, & Gorman, 1999). However, the latest evidence reveals 
that enhanced CVR may also directly contribute to the inflammatory etiology of 
atherogenesis, the precursor to CHD (Lovallo & Gerin, 2003). 
Overview of Inflammatory Responses to Anger 
Atherogenesis begins with the development of atherosclerotic lipid-filled 
macrophages, known as foam cells, which contribute to plaque formation within 
the endothelial lining of the arterial blood vessels. Plaque formation initially 
occurs in areas where there is increased turbulence from shear forces such as 
bifurcations in carotid and coronary arteries. Macrophages, along with circulating 
monocytes, add to the ongoing thickening of these plaques and the development 
of new plaques through the innate immune response (Lovallo & Gerin, 2003). 
The innate immune response mounts a localized inflammatory response, which 
results in the release of communication molecules known as cytokines.  
Cytokines are glycopeptide-signaling molecules that regulate both innate 
cell-mediated immunity and humoral immunity including the acute phase 
response, which provoke key steps involved in immune responses that include T- 
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and B- lymphocytes, monocytes, and macrophages (Maes et al., 1998). The pro-
inflammatory cytokines, specifically interleukins IL-1, IL-6, and TNF!, have been 
identified and found to be increased in systemic inflammation and are beginning 
to be recognized as biochemical markers of poor health outcomes associated 
with cardiac disease, diabetes mellitus, and osteoporosis (Segerstrom & Miller, 
2004). TNF!  has been found to alter endothelial cell function and promote the 
expression of adhesion molecules which contribute to accumulation of cellular 
debris and promote the production of CRP (Suarez, Lewis, & Kuhn, 2002).  
C-reactive protein is an acute phase reactive protein released by the liver 
that is activated by the release of pro-inflammatory cytokines, particularly IL-6, 
and appears to play a role in the development of atherogenesis and subsequent 
CHD (Hapuarachchi, Chalmers, Winefield, & Blake-Mortimer, 2003). In response 
to elevated levels of IL-6 following inflammation, infection, tissue injury or stress, 
CRP is thought to directly activate endothelial cells to express cellular adhesion 
molecules which further contribute to vascular inflammation (Gotto, 2006). Based 
on large prospective studies, CRP has been shown to be a reliable biomarker of 
underlying systemic inflammation and a strong predictor of future myocardial 
infarction and stroke (Willerson & Ridker, 2004). Contemporary research in PNI 
suggests that psychological stress-induced changes also contribute to the 
increased production of pro-inflammatory cytokines and lymphocytic alterations 
(Black, 2006; Black & Garbutt, 2002; Bryndon et al., 2005; Lovallo & Gerin, 2003; 
Padgett & Glasser, 2003; Segerstrom et al., 2001).  
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Research on Cardiovascular Reactivity Responses to Anger 
         The particular mechanism linking anger to CHD and hypertension remains 
elusive. One leading hypothesis implicates activities of the sympathetic 
adrenomedullary system and the hypothalamic-pituitary-adrenocortical axis. In 
reaction to psychological stress, such as an angry emotional response, excess 
stress hormones including catecholamines and corticosteroids may negatively 
impact CVR by increasing platelet aggregation which leads to endothelial injury 
and plaque formation triggering the surge of proinflammatory actions involved in 
atherogenesis described above (Williams, Couper, Din-Dzietham, Nieto, & 
Folsom, 2007).  
 Anger and CVR have been extensively studied and measured with various 
instruments relative to risk of CHD, hypertension, and stroke; both positive and 
negative associations have been found. Fontana and McLauglin (1998) used 
Lazarus’ stress and coping framework to measure whether stressful situations 
might predict heart rate and blood pressure and hypothesized that the more 
stressful the perception of daily stressors, the higher CVR would be. Differences 
in problem-focused or emotion-focused coping processes and appraisal of daily 
stressors were thought to predict physiological response to stress. A small 
sample of 33 college women were measured pre- and post-menstrual cycle while 
performing mental arithmetic and interpersonal conflict tasks within an anger-
provoking paradigm. Results demonstrated that tension reduction techniques and 
positive appraisal were related to lower CVR while anger suppression increased 
CVR. The researchers concluded the transactional model of stress could assist 
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in generating further ideas about which psychological factors might predict CVR 
(Fontana & McLauglin).   
Webb and Beckstead (2002) looked at the relationship between blood 
pressure, anger, coping resources, and strain. In the 90 African-American 
women who were studied, women with elevated blood pressure, and women 
treated for hypertension had higher anger suppression scores than normotensive 
women. These findings approached statistical significance (p=.06) after 
covariates (age, waist/hip ratio, and pack-year smoking history) were entered. 
The clinical significance of this study may imply that anger and stress 
management interventions for women with elevated blood pressure and 
hypertension might be helpful in the prevention and progression of 
cardiovascular disease. 
The use of mental arithmetic tasks described above (Fontana & 
McLauglin, 1998), challenge tasks, videogames and hostile, challenging 
confederates in staged discussions have been used in a number of studies to 
induce anger states while different measures of CVR were collected. Abel et al. 
(1995) studied 67 female college students’ anger expression styles during video 
gaming and mental arithmetic tasks while measuring heart rate and blood 
pressure changes. Anger expression as measured by Spielberger’s highly 
reliable Anger Expression Scale revealed that women who had moderate anger-
out styles had lower blood pressure responses to the arithmetic stressor than low 
(p=<0.05) or high (p=0.01) anger-out women. The latter group had the highest 
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reactivity to the arithmetic task compared to the moderate anger-out group 
(p=0.05). 
Bongard et al. (1997) used a 4-way experimental design to look at CVR 
response to a mental arithmetic task. Active coping style, number reading 
(nonactive coping), and anger provocation versus no provocation were compared 
to reports of angry feelings. Large effect sizes (p= <0.001) were seen in 
provoked participants’ heart rates, diastolic blood pressures, and angry affect. 
Although the experimental design of the study was well thought out, the lack of 
information including reliability and validity of the scale to measure affect limits 
the applicability of findings. 
Lawler et al. (1998) also used a mental arithmetic challenge and an anger 
recall interview in an exploratory study to determine whether college students 
with a family history of hypertension would have greater physiological responses 
to anger than those without. For men, large effect sizes (p=<0.001) were found 
for cardiac output and in women, for total peripheral resistance (p=<0.004). All 
measures at baseline were higher in those with positive family history 
(p=<0.001). Less significant correlations were found between low anger 
expression, low anger experience, and high anger control with the math 
challenge on all measures of CVR in those with positive family history (p=<0.10). 
In another study of college women, Powch and Houston (1996) also used 
confederate discussion and challenge to measure psychological variables while 
subjects were provoked during blood pressure and heart rate recordings. 
Relationships between cynicism, mistrust, disagreeableness, and anger-in were 
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studied with the Cook-Medley Hostility Scale, State-Trait Anger Scale, and two 
other less reliable instruments. High hostility was related to greater systolic blood 
pressure reactivity during high interpersonal stress (p=<.001), however no 
significant relationship was found to anger-in among this all white sample. 
In a similar study reported by Davis, Matthews, and McGrath (2000) 
college students with high hostility had significantly (p=<0.05) larger increases in 
diastolic blood pressure and total peripheral resistance than low hostile 
individuals when engaged in a controversial topic discussion with a confederate 
who was argumentative and aggressive.  Although no effect was seen on affect 
response of the students as to difficulty of task, the perception of interpersonal 
control varied by level of hostility. This raised the question whether low and high 
hostile individuals perceive their interactions during their everyday lives in terms 
of their perception of control. 
Lavoie, Miller, Conway, and Fleet (2001) used a subject friendship quality 
scale with physiological recordings to see if greater elevations in women’s blood 
pressure, heart rate, cardiac output, stroke volume, and total peripheral 
resistance would be seen in an anger-provoking situation in defense of self or 
defense of their friend. Equal significant effects (p=<0.01) of anger, irritation, and 
annoyance resulted whether they or their friend were harassed but only women 
in the self-harass group had very significant elevations (p=<0.001) in peripheral 
resistance.  
Even though these six studies were conducted with college students in a 
laboratory, all anger responses resulted in increased CVR and theoretically 
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increased the risk for development of CHD. However, one of the questions often 
raised in an analysis of studies on anger is whether simulated anger situations 
cause the same physiological and psychological reactions to anger as those 
experienced within every day lives of women. As noted by Brondolo et al. (2003) 
individuals in a laboratory setting may use different strategies for expressing 
anger than in unobserved “real life” interactions (p. 1003). 
Although Thomas (1997) found no main effect for anger frequency or 
intensity in blood pressure changes in a community sample of 210 women age 
18 to 71, suppressed anger, especially in the home setting with spouse or best 
friend, was positively related to elevated blood pressure. Thomas hypothesized 
that anger suppression in women and elevations in blood pressure as a result of 
interpersonal conflicts and daily stressors may be of greater significance than 
blood pressure elevations related to an angry event with a stranger. 
Horsten et al. (1999) asked about the association of social isolation, 
depressive symptoms, anger, and heart rate variability (HRV). Using the concept 
of allostasis, which proposes that physiological systems within the body fluctuate 
to meet demands from external forces, they hypothesized that psychosocial 
strain, as a stressor, may be related to decreased HRV in a healthy population 
and an important measure of disturbed autonomic nervous system. Using a large 
(n=300) random sample of healthy women, scores from the Stress Process 
Questionnaire (Cronbach’s alpha=.85) and the previously validated Framingham 
Anger Scale were correlated with 24-hour EKG recordings, social support 
systems, and lifestyle factors. Although no effect was seen on three of the four 
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anger scales, not discussing anger was associated with decreased HRV; being 
married and larger household size showed a similar association. This study 
demonstrated the effect of daily psychosocial strain as a possible antecedent to 
CHD, especially in women who lived alone, reported lack of social support, and 
did not relieve anger by talking to others. 
Harris, Matthews, Sutton-Tyrell, and Lewis (2003), questioned whether 
psychosocial traits are related to endothelial function. They hypothesized that 
negative psychosocial characteristics may be risk factors for CHD and that 
circulating estrogens and hormone replacement therapy (HRT) may be protective 
in delaying declines in endothelial function. The use of the highly valid and 
reliable Bortner Type A Rating Scale, Framingham Tension Scale, Beck 
Depression Inventory, and Spielberger Trait Anger and Anxiety Scales revealed 
that Type A behavior, anger, anxiety, and depression were significantly (p <.05) 
related to impairments in endothelial function among 193 healthy 
postmenopausal women. However, some of these relationships may be masked 
by HRT. 
Type A behavior pattern and CVR were explored by Anderson and Lawler 
(1995) in a mixed methods study of 58 female students between 18 and 42 years 
old. A semi-structured interview recalling an anger incident was analyzed against 
blood pressure, heart rate, and classification of Type A and Type B personalities. 
There was a main effect of behavior on diastolic blood pressure in Type A 
women (p=<0.02) in response to frustration over autonomy needs. Type B 
women had higher CVR in response to frustration over affiliation needs. Further, 
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all women who suppressed anger had higher CVR than those who expressed 
anger. Given the known relationship of Type A personality and CHD, chronic 
anger suppression may be an additional risk factor for CHD. 
Utilizing a similar framework that chronic anger suppression may 
exacerbate potential or existing CHD and contribute to early mortality, Fichera 
and Andreassi (1998) hypothesized that women who demonstrate high CVR to 
some stressor are more likely to develop CHD. Looking at reaction time to an 
oral IQ quiz, Type A women showed significant (p=<0.05) increased CVR on 
both reaction time and oral quiz compared to Type B, women but the Type A high 
hostile women were more reactive (p=<0.05) than Type B low hostile women. 
As measured in the social milieu of the everyday lives of women, anger 
suppression alone and in combination with a Type A personality may further 
increase a women’s risk for CHD. Analysis of several prospective studies does 
provide evidence of possible links between these variables especially in relation 
to anger suppression and hostility, although many of the studies had small 
numbers of women or were completed on men. 
Everson, Goldberg, Kaplan, and Salonen (1998) described the 
relationship between anger expression and hypertension in a four-year 
prospective study of 537 men and found a large effect of anger-out (p=<0.002) 
and anger-in (p=<0.01) and hypertension, increasing risk of hypertension by 12% 
for every 1 point increase in either scale of anger expression. Findings from this 
study could not be implied for women. 
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Harburg, Julius, Naciroti, Gleiberman, and Schork (2003) utilizing the 
conceptual framework that chronic suppressed anger exacerbates potential or 
existing pathology and leads to mortality, prospectively .considered the landmark 
Tecumseh Community Health Study to assess anger-coping styles in men and 
women. Responses to hypothetical anger-provoking scenarios were examined in 
relation to anger styles, blood pressure, and all cause mortality. Women showed 
a significant (p=<.01) relationship between suppressed anger and risk of early 
mortality for all-cause CHD, and cancer endpoints. 
Similar findings were reported by Raikkonen, Matthews, and Kuller (2002). 
In a large prospective study (n=425) women who had high levels of depression, 
tension, and anger at baseline had elevated risk for developing metabolic 
syndrome 7.4 years later (p=<.04). Further, a reciprocal relationship between 
development of metabolic syndrome and increasing anger were found over time 
(p=<.001). Although CVR was not measured, hypertension is one of the criteria 
for metabolic syndrome.  
In another large prospective study of 688 women, Rutledge et al. (2001) 
also looked at cardiac related variables to determine associations between 
atherosclerosis risk factors and psychological characteristics linked to CHD. 
Anger expression was significantly related to dyslipidemia and larger body mass 
index (BMI). A four-fold increased risk was found between high anger-out, high 
levels of low-density lipoprotein (LDL), and low levels of high-density lipoprotein 
(HDL). Although not measuring CVR directly, high LDL and low HDL contribute to 
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the development of atherosclerosis and CHD. Therefore, the implication that 
anger-out is related to the development of CHD may be made. 
Troxel, Matthews, Bromberger, and Sutton-Tyrell (2003) took a random 
sample (n=334) from the longitudinal Study of Women’s Health across the Nation 
(SWAN) study and found significant differences in carotid artery intima thickness 
in African-Americans. Looking at biobehavioral risk factors related to chronic 
stress, they found combined stressors, economic hardship, and unfair treatment 
(an antecedent to anger) were associated with increased subclinical carotid 
artery disease over time.  
Hostility, which is generally described as a more pervasive and enduring 
antagonistic mental attitude (Thomas, 1993), has been extensively studied and 
measured in several prospective studies of men and women (Brondolo et al., 
2003; Matthews et al., 1998; Williams et al., 2000; Williams et al., 2001). All of 
these studies showed large significant effects of high trait anger, strong angry 
temperament, and high trait hostility with increased CVR. In the Atherosclerosis 
Risk in Community (ARIC) Study, Williams et al. (2000, 2001, 2007) showed a 
twofold increased risk in CHD and threefold increase risk for CHD events and 
subclinical atherosclerosis in over 13,000 men and women who were studied 
over 5 years that scored high in trait anger and angry temperament. Hostility was 
found to be an independent risk factor for recurrent CHD events in women from 
the Heart and Estrogen Replacement (HERS) study that were followed for four 
years (Chaput et al., 2002).  
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Brondolo et al. (2003) wrote that the transactional model suggests that 
hostility influences health partly through its effects on social relationships and 
that increased CVR associated with interpersonal and other stressors may 
contribute to development of CHD. However, they cautioned that the cognitive, 
affective, and behavioral measurements of hostility as measured by the Cook-
Medley Ho scale are associated in different ways to CHD and the 
subcomponents of hostility that measure negative interpersonal reactions and 
CVR correlates have not been adequately studied. 
        In summary, the majority of the studies of anger and CVR were descriptive 
and correlational with small effect sizes. Two thirds of the studies used well-
known and reliable instruments, however interpretation of results was limited by 
inadequate definitions and distinctions between the constructs of anger and 
hostility. Most of the studies used convenience samples of college students and 
were further limited by inadequate samples of women and minorities. However, 
ten large prospective studies used community samples with some reporting 
significant correlations between anger and other psychosocial factors, 
hypertension, CHD and carotid atherosclerosis. These results provide good 
evidence for the anger-CVR connection. 
Research on Inflammatory and Immunological Responses to Anger  
Research examining immunological relationships and anger are meager 
and have been mostly examined within the context of the role of inflammation as 
a precursor to CHD. However, the findings from these studies tend to indicate 
that an angry emotional state has an effect on changes in natural killer (NK) cells, 
  
22 
 
natural killer cell activity (NKCA), and CRP. The negative impact on inflammatory 
and immune responses provide further support for the role of atherogenesis in 
the development of CHD. 
Mills, Dimsdale, Nelesen, and Dillon (1996) seeking possible relationships 
between CVR and immune reactivity, looked at the connection between anxiety, 
anger expression, hostility, and enumerative immune responses to a 6-minute 
laboratory speech stressor in 104 healthy community volunteers. Citing prior 
research that had found stress, depression, and interpersonal conflict to be 
associated with long-term immune dysfunction, and daily hassles associated with 
short-term immunological changes, Mills et al. measured acute immune reactions 
by videotaping subjects’ oral defense against a false accusation of shoplifting. 
Pre- and post-speaking biochemical and psychological measurements were 
obtained to determine the effects of the speaking stressor on the various cell 
populations. Multiple linear regressions were analyzed to determine factors 
associated with cellular responses and psychological characteristics, accounting 
for age and smoking status. Leukocyte populations were analyzed via flow 
cytometry and quantified by total white blood cell count, lymphocyte subsets, and 
NK cells. NK cells are a class of lymphocytes that attack and kill malignant cells, 
foreign cells, and virally infected cells. 
Moderate but statistically significant (p<.03) associations between NK cell 
responses and anger expression suggested that persons who expressed angry 
emotions had lower increases in immune response compared to individuals 
identified as hostile with higher numbers of NK cells (p=.02).  
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Suppressor/cytotoxic cell increases were related to pre- and post-anxiety scores 
with those reporting the greatest amount of chronic stress showing the smallest 
acute increases in WBC (p=.006). Overall, these findings suggested that certain 
emotional responses or personality characteristics, like anger and hostility, may 
be associated with short-term immune function changes, similar to CVR 
responses, reinforcing the PNI connection (Mills et al., 1996). 
Larson, Ader, and Moynihan (2001) also employed an acute laboratory 
stressor to identify correlates of neuroendocrine, immune, and CVR responses 
by examining stress-related changes in NKCA, cortisol, and cytokines that elicit 
macrophage and antibody activity, interferon gamma (IFN-g), and interleukin-10 
(IL-10) in 56 healthy subjects. Heart rate, blood pressure, and blood samples 
were obtained 30 minutes before, during, and immediately after a stress-inducing 
speech task in which subjects were asked to describe their best and worst 
characteristics. Additionally, they were under the assumption that they were 
being evaluated by psychologists to determine how persuasive each subject’s 
speech was compared to each other.  As expected, increased CVR was seen all 
subjects and 91% showed significant increases in NKCA (p<.001); 69% showed 
significant IFN-" increases (p<.009). NKCA was found to be significantly and 
positively correlated with CVR (p<.004). Anger suppression was also found to be 
significantly and positively correlated with CVR (p<.02), cortisol (p<.007) and IL-
10 (p<.02).  Of note, the use of almost 40 regression equations at a significance 
level of p<.05 likely led to some spurious findings. However, the hypothesis that 
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increased anger suppression as a psychological risk factor for increased CVR 
and lowered altered immune response was supported. 
An early PNI study examined how emotion contributes to immunologic 
changes in response to psychological stress during marital conflict. Miller, Dop, 
Myers, Stevens, and Fahey (1999) explored the idea that emotions induced by 
naturalistic stressors would also elicit stress-induced changes in immune 
parameters. They hypothesized that spouses would respond with negative 
emotions to an episode of marital conflict and these responses could be 
measured by increases in blood pressure, heart rate, circulating catecholamines, 
and increases in NK cells, NKCA, and CD8 T-lymphocytes. Further, they sought 
to determine if the relationship between anger and physiological changes was 
moderated by hostility. Married couples (n=113) were extensively screened to 
reduce confounders that might be produced by pre-existing medical, social, and 
lifestyle conditions. From this pool, 41 couples completed a marital problem 
inventory and several psychological scales prior to having blood samples and 
biological measurements taken. Based on their responses to the marital problem 
inventory, the researchers suggested a topic (such as household management or 
communication) that had been identified by both spouses as a source of conflict.  
During a 15-minute videotaped problem-solving discussion, several blood 
samples, heart rate, and blood pressure measures were taken, concluding with a 
final sample taken after a 25-minute rest period at the end of each couple’s 
session. Emotional affect scores were also developed by trained observers who 
assigned one of nine emotion codes to each subject for every 5-second interval 
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of discussion. Scores were used to compute a series of correlations between 
affect scores and reactivity and recovery scores for each of the physical 
parameters.  
Controlling for baseline physiological values, partial correlations revealed 
that high levels of husbands’ affective anger covaried with greater systolic blood 
pressure increases (p<.01) but wives’ anger did not. Affective anger scores for 
both genders were unrelated to neuroendocrine and immune parameters during 
and after conflict discussion. Husbands who scored high on hostility showed 
significantly greater increases in NKCA during discussion and less recovery 
response (p<.01). Also, higher levels of anger covaried with greater increases in 
NK cell numbers during discussion (p<.05) but were unrelated to recovery. No 
significant findings were found in any parameters for wives. In general, men high 
in cynical hostility displayed more anger during conflict and had greater increases 
in heart rate, blood pressure, cortisol, NK cells, and NKCA.  
The lack of similar findings in women in this observational design was 
thought to be possibly related to the differences in the more pronounced 
testosterone secretion elicited in men during anger expression. Perhaps, as 
pointed out by Abel et al. (1995), the overall differences in anger expression 
among men and women affected how emotion coding was recorded in that what 
may have been an angry response by a wife was coded as dissatisfaction or 
sadness, rather than anger. Further, the large number of statistical comparisons 
likely produced some correlations that were actually due to chance. 
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A naturalistic stress design was used to study lymphocyte proliferation in 
spousal caregivers of persons with Alzheimer’s disease (Scanlan, Vitaliano, 
Zhang, Savage, & Ochs, 2001). Dyads of 82 spouse caregivers of patients with 
Alzheimer’s and 83 age- and gender-matched spouses of normal controls were 
included in the final analysis of carefully screened volunteers. Extensive inclusion 
and exclusion criteria, as well as psychiatric and medical confirmations of a 
diagnosis of Alzheimer’s disease in the absence of all other neurological, 
cardiovascular, and immune related diseases, medications, psychological 
disorders, etc., supported this repeated-measures design to eliminate as many 
confounding variables as possible. 
Participants completed several psychological instruments which were 
correlated to lymphocyte proliferation responses to mitogens. Mitogens are 
agents that induce in vitro mitosis and are considered a reliable measure of 
immune system function in depressed subjects (Vedhara & Irwin, 2005). For 
anger-related measurements, in all cases and both times, no statistically 
significant main effect of anger expression was found. However, anger 
expression did significantly interact with caregiving status at Time 2 (but not at 
Time 1) for all changes in lymphocyte production resulting in lower immune 
responses (p<.05) and was negatively correlated in caregivers. Caregivers with 
the highest levels of outward anger expression showed significantly lower 
mitogen responses than those with controlled anger expression styles (p<.05).  
The authors concluded that these results appeared to be consistent with 
other findings (Mills et al., 1996) that suggest high degrees of anger expression 
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and/or hostility may be the anger components most likely associated with 
negative health outcomes as a result of decreased immune response. However, 
since stress-related hormones (cortisol and catecholamines) may also mediate 
relationships of depression and anger with lymphocytic proliferation, lengthier 
longitudinal studies are needed to determine if altered immune responses result 
from anger or depression alone or the synergistic effect of both emotions. 
Suarez (2003) examined the relationship of IL-6 to anger, hostility, and 
depression as a function of multivitamin (MVI) supplement use in 96 healthy, 
non-smoking men. Based on studies that reported daily use of antioxidants 
and/or MVIs had been linked to reduced morbidity and mortality from 
cardiovascular disease, Suarez hypothesized that anger, hostility, and severity of 
depressive symptoms independently and as a composite psychological risk 
factor score, would be positively associated with IL-6 among non-MVI users 
compared to those taking MVIs.  Following collection of blood samples, subjects 
completed depression, hostility, and personality inventories which were then 
used to generate a composite psychological risk score. Serial multiple regression 
analysis was used to test the combined psychological risk factor score with MVI 
use on IL-6 levels. IL-6 levels were significantly and independently positively 
correlated with all psychological measures including the composite score (p<.05) 
with the exception of the personality inventory (p<.10) in the non-MVI users; 
significant correlations were not found for these same associations in the MVI 
users. The individual instruments were significantly and positively intercorrelated 
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(p<.01), providing support for their use of a composite psychological risk factor 
score.  
These findings suggest that significant associations between IL-6 and 
psychological risk factors were moderated by the use of MVI supplements among 
healthy men, especially those who might have a propensity to exhibit anger 
and/or hostility. Limitations included the lack of testing for differences in health 
behaviors in the high and low psychosocial risk factor groups as well as the 
comparison of traditional risk factors for CHD (body mass index, resting blood 
pressure, cholesterol, etc.), serum vitamin levels, and testing of only male 
subjects. 
Based on studies looking at recognized psychosocial risk factors for CHD, 
such as poverty and depression that are known to increase TNF!, Suarez, 
Lewis, and Kahn (2002) proposed that anxiety, hostility, and anger would be 
associated with increased TNF!  secretion in lipopolysaccharide stimulated 
cultures and would also be identified as additional psychosocial risk factors for 
CHD. Lipopolysaccharide (LPS) is a natural endotoxin released by Gram 
negative bacteria which powerfully and non-specifically stimulates immune 
responses in vitro. Subjects were 62 healthy, non-smoking males who completed 
a psychological inventory that included a 5-item anger subscale prior to analysis 
of LPS-stimulated blood samples for TNF!  expression. Parallel multiple 
regression models supported their hypothesis and showed significant positive 
correlations between total anxiety, hostility, and anger scores and 
TNF! expression (p=.007). Limitations included the constricted focus of anger in 
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the psychological inventory that was used and that depression, which has also 
been associated with increased TNF!  expression, was not measured in this 
study. Therefore, since the unique and combined relationships of psychological 
risk factors of CHD such as depression, anger, hostility, and aggression also 
affect inflammatory responses (Everson-Rose & Lewis, 2005), these results 
should be interpreted with caution. 
Suarez, Lewis, Krishnan, and Young (2004) conducted a study of hostility 
and depressive symptoms in 44 women to determine if LPS-stimulation of 
monocytes was correlated in a similar fashion as in men. Healthy, non-smoking, 
premenopausal women were recruited and screened for medical and 
psychological conditions that could alter monocyte marker expression (e.g. oral 
contraceptives). Separate and combined effects of hostility and depression were 
examined on the capacity of blood monocyte expression of IL-1, interleukin-8 (IL-
8), TNF!, and monocyte chemotactic protein, which stimulates up-regulation of 
cellular adhesion molecules on endothelial cells, leukocytes, and platelets. 
Separate depression inventory and hostility scales were used to assess 
psychological symptoms and scores were compared individually and as a 
composite psychological risk factor score. Multiple regression formulas were 
used to look at BMI, total cholesterol, race, alcohol, 17b estradiol, and 
progesterone levels as covariates. In contrast to their earlier study (see above), 
anger expression was not measured, yet results for this study were reported as 
similar. Hostility and depression scores, but not psychological risk factor scores, 
were associated with greater general expression of proinflammatory cytokines 
  
30 
 
(p<.05). Significant results were also noted when all scores were used to predict 
LPS-stimulated expressions (p<.05). However, there were enough variances by 
level of hostility and severity of depressive symptoms in that some cytokines 
were up-regulated and others were not. Hostility enhanced expression of IL-1 
and IL-8, while depression was associated with increased expression of TNF!  
and IL-8 but not IL-1. Therefore, conclusions based on the general directions of 
the associations using a psychological risk factor score and causality could not 
be made.  
Hapuarachchi, Chalmers, Winefield, and Blake-Whitemore, (2003) 
measured homocysteine, CRP, salivary immunoglobulin-A (IgA), and lymphocytic 
5’ectonucleotidase (NT) using a theoretical model that psychological stress is 
associated with a pro-inflammatory state as a result of increased lymphocyte 
mobilization and subsequent higher cellular oxidative stress.  Lymphocytic NT is 
a lymphocytic maturation marker and has been found to have a lower activity 
level in decreased immunity states and is a measure of oxidative stress. 
Oxidative processes produce free radicals which damage cells and initiate 
inflammatory reactions.  
Forty three participants volunteered blood and saliva samples and 
completed various psychometric questionnaires, including an anger expression 
scale. Correlation analysis was used to examine the strength of the relationships 
between psychological and biochemical parameters. CRP was significantly and 
positively correlated with outward expression of anger and anger experience 
(p<.05) and significantly negatively correlated with anger control (p<.05). These 
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findings may indicate that a pro-inflammatory state is associated with 
unmanaged anger expression while a cognitive anger coping style was not. 
Limitations included the use of a cross-sectional design that mostly relied on 
correlational analysis and therefore causality cannot be implied. Additionally, the 
authors acknowledge the subjects’ individual cognitive perceptions of overall 
stress and the stress-illness process are multifactorial and complex. Also, other 
variables could be confounding the results.  
The relationship of psychological factors that influence the immune system 
and accelerate the progress of CHD was explored by Ishihara, Makita, Imai, 
Hashimoto, and Nohara (2003) who focused on anger expression. Known CHD 
subjects were matched with healthy controls and measurements of NKCA were 
analyzed against anger expression scores. In the CHD group, NKCA was found 
to be significantly elevated (p<.05) by the suppression of anger and negative 
emotions. Since this study was not prospective, the researchers were uncertain 
whether the development of CHD or the power of psychological factors 
influenced the immune response and promoted CHD. Additionally, the lack of 
concomitant measurements of T-lymphocytes and cytokines limited any 
implications of causation. Ishihara et al. speculated, based on this study and 
earlier studies referenced in their findings, that emotional states such as anger 
experienced in day-to-day living are the function of an acute psychological stress 
response that up-regulates NKCA, and that suppression of anger is an important 
factor that increases NK cell numbers through enhanced sympathetic and 
endocrine system responses. 
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Gouin, Kiecolt-Glaser, Malarkey, and Glaser (2008) recently published 
their findings related to patterns of anger expression on wound healing. They 
proposed that outward and inward expression of anger and lack of anger control 
would be associated with delayed healing of standardized blister wounds. The 
Anger Expression Scale of the STAXI-2 was administered (along with five other 
psychological questionnaires) to 98 (40 men and 58 women) community-dwelling 
subjects who were part of a larger study of the effects of relaxation on wound 
healing. Salivary cortisol and IL-1a IL-1b IL-6, IL-8, and TNF!  were examined in 
both the relaxation intervention group and the control group over an eight-day 
period. 
The rate of healing did not differ between groups and no significant 
differences were found in anger expression, however, results showed that higher 
levels of anger control were associated with a higher level of wound healing at 
day four (r=.45, p=<.01) even after differences in hostility, negative affect, sleep, 
exercise, etc., were controlled. Anger out and anger in separately were not 
related to speed of healing. Overall, individuals displaying less anger control 
secreted more cortisol (but not cytokines, which were measured at the wound 
site). This was the first study showing that anger dysregulation may delay 
healing. 
Summary of Review of Literature 
To summarize, research studies examining immunological relationships 
and anger are meager and have been mostly examined within the context of the 
role of inflammation as a precursor to CHD. As noted earlier, anger and 
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cardiovascular reactivity have been extensively studied and measured with 
various instruments relative to risk of CHD, hypertension, and stroke revealing 
both positive and negative associations. The cited PNI studies tend to indicate 
that an angry emotional state may affect changes in NK, NKCA, CRP, and some 
cytokines, contributing to the negative impact of inflammatory and immune 
responses which further contribute to atherogenesis and the development of 
CHD. 
The majority of these studies were done on young, healthy, primarily male 
populations with the use of multiple psychometric or psychological scales that 
were subjected to extensive correlational analyses. Other studies used principal 
components analysis to generate a composite personality factor score that may 
not truly represent anger trait as a personality characteristic. The primary use of 
correlational analysis in cross-sectional designs, especially with numerous 
instruments, contributes to loss of statistical power and increases the likelihood 
of spurious findings. Limited reports of repeated measures and prospective 
designs greatly limit interpretation of data from this review. 
Further, the blurring of the constructs of anger, hostility, and aggression, 
and use of anger subscales from larger hostility, anxiety, depression, and other 
psychosocial and personality instruments, as well as the lack of clarity in 
describing anger expression, anger control/suppression, and other 
characteristics of anger style, have made interpretation and generalizability of 
research findings difficult. As Spielberger et al. (1985) pointed out over 20 years 
ago, definitions for anger used in research instruments are often inconsistent and 
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ambiguous. Most studies made use of self-report anger subscales of hostility, 
anxiety, aggression, and depression inventories; few used only unique anger 
expression scales, and only two studies measured anger trait as a separate 
personality variable. 
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Chapter Three:  Methodology 
Study Design, Setting, and Sample 
   A quantitative, cross-sectional between-groups design was used to 
examine differences in CRP between high and low anger groups. The researcher 
completed administration of all research instruments and questionnaires 
exclusively. Participants who met the inclusionary/exclusionary criteria as 
determined by the researcher were tested individually in a reserved private room 
in the student health center at Florida Gulf Coast University in Ft. Myers, Florida. 
All procedures were reviewed and approved by the Florida Gulf Coast University 
and the University of South Florida (USF) Institutional Review Board (IRB# 
106379D) and conducted according to protocols outlined by the USF Human 
Research Protections Program. 
  The study was conducted on a convenience sample of healthy 
community-dwelling women recruited from an urban college campus in 
southwest Florida. Participants were recruited through announcements 
(Appendix A) and networking to faculty, staff, and women’s groups, via 
electronic mail, and recruitment posters placed in common areas, such as 
the SHC, cafeteria, student union, and library. Men were excluded because 
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women have been understudied in research examining anger and 
cardiovascular disease risk (Abel et al., 1995; Kielcolt-Glaser, McGuire, 
Robles, & Glaser, 2002).  
  Eligible women were between the ages of 45 and 65 and either post-
menopausal or post-hysterectomy. Women under the age of 45 were excluded 
because CHD normally develops during middle age. Women who were still 
experiencing menses were excluded to control for the effect of endogenous 
hormone levels. To insure a healthy sample, participants were non-smokers, not 
on any hormone contraceptives or hormone replacement therapy, had no history 
of any cardiovascular diseases (CHD, congestive heart failure, transient ischemic 
attacks, stroke, etc.), diabetes mellitus, autoimmune diseases, severe mental 
illness, or recent (90 days) history of acute infection, trauma, major surgery, or 
other inflammatory conditions such as chronic bronchitis, gastric inflammation, 
chronic renal disease, or recent (10 day) history of minor surgery. Participants 
who were taking medications that are known to confound PNI studies 
(cholesterol-lowering agents, prescribed non-steroidal anti-inflammatory drugs, 
cortisone, prednisone, and other steroid preparations, large doses [more than 
650 mg] of aspirin, etc.) were also excluded (Zeller, McCain, McCann, Swanson, 
& Colletti, 1996). Participants who smoked cigarettes and/or used recreational 
drugs, or drank more than two alcoholic beverages daily were excluded as these 
substances are also known to increase CRP independently (Zeller). 
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 Procedures 
 Women who either called or emailed in response to recruitment 
announcements were told that the total time to complete the initial study 
instruments (which would determine whether they qualified for the rest of the 
study) would take less than 10 minutes and if they were suited for the study, an 
additional 15 to 20 minutes would be needed to complete the second part of the 
questionnaire, and an additional 5 minutes to obtain their waist measurement 
and a sample of their blood. Women who agreed to volunteer for the study were 
given an appointment to meet with the researcher at which time further 
information was provided regarding the risks and benefits of participating in the 
second part of the study, particularly in relation to the need for providing a blood 
sample. Women were told they might feel slight discomfort from having a needle 
poked into their vein and that there might be a small chance of a bruise at the 
place where the sample was taken. 
 Women were informed they would need to provide personal information 
about their age, race/ethnicity, marital status, and years of education. Women 
were assured that their personal information would be kept confidential by the 
researcher and numerically coded to prevent any association between their 
biographical information and their scores on the various research instruments, 
waist measurements, and blood samples. Participants were reminded that their 
inclusion in the study was voluntary and they could withdraw from the study at 
any time, for any reason without any adverse effects to their status as a member 
of the community.  
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 Following completion of the verbal explanation of the study, the 
investigator reviewed the written informed consent form (Appendix B) with each 
woman. After answering any questions posed by the subject, women were asked 
to read and sign the informed consent form. Subjects then completed a 
researcher-designed questionnaire (Appendix C) to verify study inclusion criteria 
were met and were assigned a unique identification number. Next, qualifying 
participants were asked to complete the biographical data section of the State-
Trait Anger Expression Inventory-2 (STAXI-2) and provide information about their 
age, race/ethnicity, marital status, and years of education (Appendix D).  Next, 
subjects were asked to complete the Trait Anger subscale of the STAXI-2. Upon 
completion of the subscale, the researcher immediately tallied each subjects’ 
responses and those women who scored in the uppermost quartile (high anger) 
and lowest quartile (low anger) of the trait anger subscale (as determined by the 
age-matched normative groups provided in the STAXI-2 Professional Manual 
[Psychological Assessment Resources, 1999]) were then asked to complete the 
Anger Expression subscale of the STAXI-2. Women who failed to score in either 
quartile were thanked for their time and excused. 
           Because there is a strong relationship (r>.35) between waist 
circumference and CRP (Festa et al., 2001), immediately following completion of 
the STAXI-2, the researcher measured and recorded the subject’s waist 
circumference using a cloth measuring tape placed at the top of the iliac crests 
and around the umbilicus. 
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 Finally, using universal precautions, a licensed practical nurse  obtained a 
5 millimeter blood sample from each subject via antecubital venipuncture into 
serum separator tubes and immediately refrigerated at 5º C. Subjects were 
offered a $10.00 cash payment and thanked for their participation. 
 Within 24 hours of collection, the researcher spun the tubes in a cold 
centrifuge at 3800 rpm for 25 minutes. Serum was immediately aliquoted and 
frozen at -80º C until retrieved for analysis. Under the direct supervision of the 
researcher’s chairperson in the University of South Florida College of Nursing 
Biobehavioral Laboratory, serum was defrosted at room temperature and 
prepared for measurement by the researcher using a high-sensitivity enzyme-
linked immunosorbent assay (ELISA). Serum was diluted 1:100 for the assay. 
 The assay uses unique polystyrene-coated monoclonal antibodies to CRP 
which in the presence of CRP agglutinate causing an increase in the intensity of 
scattered light which can be measured spectrophotometrically. The increase in 
scattered light is directly proportional to the amount of CRP in the sample. 
 Subject serum samples, reference standards, and control serum samples 
were prepared in duplicate exactly according to assay procedure protocol (DRG 
International, 2005) and measured using a plate reader at 450 nm.  A standard 
curve was produced plotting the mean absorbance obtained for each reference 
standard against its CRP concentration in mg/l with absorbance on the vertical 
axis and concentration on the horizontal access. Data reduction was 
accomplished by GraphPad Prism and obtained values of subject samples were 
multiplied by 100 to obtain CRP results in mg/l. 
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 The assay range was 0.63 mg/l to 119.3 mg/l. Expected values for adult 
serum range between 0.068 to 8.2 mg/l. Intra-assay coefficient variations ranged 
from 2.3 to 7.5% and inter-assay coefficient variations ranged from 2.5 to 4.1%. 
Assessment of Trait Anger and Anger Expression 
 Trait anger and anger expression were measured using the STAXI-2.  The 
STAXI-2 is a 57-item, two-part self-report questionnaire that assesses the 
experience, expression, and control of anger on six major scales and five 
subscales. The STAXI-2 measures State Anger, Trait Anger, Anger-In, Anger-
Out, and Anger Control. A composite Anger Expression Index is calculated from 
the combined Anger-In, Anger-Out, and Anger Control subscales and is 
computed to determine the overall level of anger expression with higher scores 
indicating greater levels of overall anger expression (Spielberger, 1999). Table 2 
describes the subscales used for this study. 
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Table 2.  
  
STAXI-2 Subscale Descriptions 
 
STAXI-2 
Subscale 
No. of 
items & 
Score 
Range 
Measurement 
 
Example 
Trait Anger  
  
 
10 
 
10 - 40 
Differences in anger 
proneness as a personality 
trait or general tendency of 
a person to get angry  
“I am a hot-headed 
person.” “When I do a 
good job and get a poor 
evaluation, I feel furious.” 
Anger 
Expression-
Out      
 
8 
 
8 - 32 
Frequency of angry feelings 
expressed in verbally or 
physically aggressive 
behavior 
“When angry or furious, I 
slam doors…argue with 
others…say nasty things.” 
Anger 
Expression-In  
 
8 
 
8 - 32 
Frequency of angry feelings 
that are experience that are 
held in or suppressed 
“When angry or furious, I 
boil inside but don’t show 
it.” 
Anger 
Control-Out 
 
8 
 
8 - 32 
Frequency of controlling 
outward expression of 
angry feelings  
“I strike out at whatever 
infuriates me.” 
Anger 
Control-In 
 
8 
 
8 - 32 
Frequency of controlling 
angry feelings by calming 
down or cooling off 
“I control my urge to 
express my angry 
feelings.” 
 
 The internal consistency of the STAXI-2 scales and subscales for normal 
adults (n=1,572) are high as measured by alpha coefficients and range from .76 
to .93 for females and .72 to .94 for males. The STAXI-2 takes approximately 15- 
20 minutes to complete and requires a sixth grade reading level or below 
(Spielberger).  
Statistical Analysis   
 Data was analyzed using SPSS Version 16.0. Preliminary analysis was 
conducted to examine the accuracy of data entry, missing values, outliers, and 
normality. Next, descriptive statistics for all variables for both high and low anger 
groups were determined. Variables were reported as means + standard 
deviation.  
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Next, differences in mean levels of CRP in women who were classified as 
high trait anger were compared to those classified as low trait anger and those 
classified as high expression anger compared to women who were in the low 
expression anger group. To determine the effect of group membership on CRP, 
an independent t-statistic compared the computed value to the critical value of t 
based on 40 degrees of freedom (df = nHIGH + nLow – 2). 
  Finally, Pearson associations of bivariate correlation coefficients between 
the anger variables and CRP and other continuous variables were examined. All 
statistical testing was conducted with a p <0.05 level of significance.  
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Chapter Four:  Results 
Descriptive Statistics 
 An initial cohort of 79 women met inclusion and exclusion criteria and led 
to the final 42-woman sample of 45 to 65 year-old post-menopausal women. 
Based on the STAXI-2 Trait Anger Subscale reference quartiles provided by 
Spielberger (1999) for females 30 and older, women were qualified for the low 
trait anger group (n=25) if their STAXI-2 trait subscale score was 14 or less or the 
high trait anger group (n=17) if their score was 21 or greater. Descriptive 
statistics for the cohort, sample, and trait groups are summarized in Table 3 and 
described below. 
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Table 3.  
 
Descriptive Statistics of Cohort, Sample, and Trait Groups 
 
Variable  
Cohort           
  n=79 
 
Sample 
n=42 
High 
Trait 
n=17 
Low 
Trait 
n=25 
 
 
Age, mean years  55.87 55.81 54.35 56.80 
Race/Ethnicity Caucasian 
69 
(87%) 
  
 
36 
(86%) 
16 
(94%) 
20 
(80%) 
 
African-
American 9  (11%) 
     
6 (14%) 1(6%)  5 (20%) 
 Hispanic 
  
1 (1%) 
 
0 0 0 
Marital Status Married 
58 
(73%) 
 
 
29 
(69%) 
13 
(76%) 
16 
(64%) 
 Unmarried 
21 
(27%) 
 
13 
(31%) 4 (24%) 9 (36%) 
Education, mean 
years  16.40 
 
16.12 15.80 16.40 
 
Anger Trait Score, 
mean  17.00 
 
 
17.00 23.71 12.44 
Anger Expression 
Index, Score, mean  
 
 
 
30.10 
 
41.59 
 
22.28 
 
Waist Circumference, 
mean inches   
 
 
33.27 33.00 33.50 
      
CRP, mean mg/L   2.74 2.69 2.77  
 
The average age for the cohort, sample, and trait anger groups were 
similar with mean values of 55.87 (+ 5.01) years for the cohort, 55.81 (+ 4.68 SD) 
years for the sample, 54.35 (+5.16) years for the high trait group, and 56.80 
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(+4.14) years for the low trait group. Caucasian women made up 87% (n=69) of 
the cohort. Of the remaining ten women, 11% were African-American (n=9), and 
1% (n=1) Hispanic. The study sample was 86% Caucasian (n=36) and 14% 
(n=6) African American. Of the high trait group, 94% (n=16) were Caucasian, 
with the remaining six percent (n=1) African-American. In the low trait group, 80% 
(n=20) were Caucasian and 20% (n=5) were African-Americans.  
Of the cohort, 73% (n=58) were married and 27% (n=21) were unmarried 
(single, widowed, divorced, or separated). Of the study sample, 69% (n= 29) 
were married and 31% (n=13) were unmarried. In the high trait group, 76% 
(n=13) were married and 24% (n=4) were unmarried. In the low trait group, 64% 
(n=16) of the women were married with the remaining 46% (n=9) unmarried.  
The average years of education for the cohort was 16.40 (+ 5.01) years 
with a range of 6 to >20 years. The average years of education for the study 
sample was 16.12 (+3.43). The high trait group mean for years of education was 
15.80 (+ 3.65) and the low trait group mean was 16.40 (+ 3.33). The average 
waist circumference for the sample was 33.27 (+ 4.99) inches with a high trait 
waist circumference average of 33.00 (+ 5.57) and a low trait mean waist 
circumference of 33.50 inches (+ 4.66).  
CRP results were positively skewed with the majority of the values at the 
low end of the range (.07 – 8.93). The study sample mean was 2.74 (+2.19) for 
the sample. The high trait group levels ranged from 0.33 to 7.71 with an average 
of 2.69 (+2.15) and the low trait mean was 2.77 (+2.29) with a range of .07 to 
8.93. Prior to data analysis, CRP values were transformed to their square roots 
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and generated non-skewed transformed CRP values that were not statistically 
different from those in a sample drawn from a theoretical normal distribution 
according to the Shapiro-Wilks test for normality. 
The average anger trait score for the cohort was 17.00 (+4.00) and ranged 
from 10 to 30 which also represents the 50th percentile score for females 30 
years and older (Spielberger, 1999). The trait score means of the high and low 
trait anger groups were significantly different (t(40)=16.54, p <.001) between 
groups. Cohen’s d was 2.62, which is considered a large effect size (Cohen, 
1999). In this study, the groups’ means were > 2.5 SD from each other indicating 
they were substantially different from each other in anger trait.  
The average anger expression index was 30.10 (+14.66) with a range 
from 7 to 62. The anger expression score means were also statistically significant 
(t(40)=5.47, p=<.001) between the high and low trait groups. The groups’ mean 
anger expression scores differed by <1 SD with a large effect size (d= .87) which 
also supports the assumption that the two trait groups are substantially different 
from each other in anger expression. 
Mean CRP Differences between High and Low Trait Anger Women 
 The first research question asked whether there were statistically 
significant differences in mean levels of CRP in women who were classified as 
high trait anger compared to those classified as low trait anger. A directional 
hypothesis was proposed that high trait anger women would have higher mean 
levels of CRP compared to low trait anger women. An independent samples       
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t-test statistic was calculated using the square root transformed CRP values and 
failed to reject the null hypothesis (t(40)=0.13, p=.90, d= 0.02). 
Mean CRP Differences between High and Low Anger Expression Women 
The second research question asked whether there were statistically 
different CRP values in women who had a high anger expression index score 
compared to those who scored low in anger expression index. A directional 
hypothesis was proposed that women who scored higher on anger expression 
would have higher mean levels of CRP compared to low anger expression 
women.  An independent samples t-test statistic was calculated using the 50th 
percentile anger index cut-off score of 29 (Spielberger, 1999) and the square root 
transformed CRP values which failed to reject the null hypothesis (t(40)=.50, 
p=.62). 
Other Findings 
 Pearson product-moment correlation (PPMC) coefficients (r) were 
assessed to determine if any variables were linearly related. As noted in Table 2, 
results of the correlational analysis showed no statistically significant 
associations between CRP and anger trait or anger expression scores. Waist 
circumference was strongly and positively correlated with CRP  (r = .48, p=.002). 
CRP was found to be moderately and negatively associated with anger control-in 
(r= -.34, p=.029). Although the relationship of CRP and anger control-out was not 
significant (r= -.28, p= .07), a smaller negative association was also noted. 
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Table 4.  
 
Correlations among C-reactive protein, Waist Circumference, Anger Trait, Anger 
Control, and Anger Expression 
________________________________________________________________ 
 Waist 
Circumference 
Anger 
Trait 
Anger 
Control-
Out 
Anger 
Control- 
In Expression Index 
________________________________________________________________ 
  .473** -.047 -.283 -.338* .197 C-
Reactive 
Protein 
        .002  .767  .070 .029 .212 
________________________________________________________________ 
  *.  Correlation is significant at the 0.05 level (2-tailed). 
**.   Correlation is significant at the 0.01 level (2-tailed). 
 
 Figure 2 depicts the scatterplot between CRP and waist measurement and 
indicates a linear relationship that as waist circumference increases, CRP levels 
also increased. Scatterplots depicted in Figures 3 and 4 show that as scores on 
the anger control in and anger control out increased, CRP levels decreased. 
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Figure 2. Scatterplot of CRP and Waist Circumference. 
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Figure 3. Scatterplot of CRP and Anger Control Out. 
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Figure 4. Scatterplot of CRP and Anger Control In 
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Chapter Five: Discussion 
 
One third of women currently over the age of forty will develop CHD in 
their lifetime. The roles of chronic and excessive inflammation are well-known 
factors that contribute to atherogenesis and CHD. Less is known about how 
stressful emotions, such as anger, are associated with proinflammatory 
processes and how unhealthy anger expression styles might contribute to CHD 
morbidity and mortality. 
Anger is a strong and generally negative emotion that includes both the 
felt emotion of anger and how anger is expressed or suppressed. Anger is also a 
common stress response based on the association of a recurrent pattern of an 
exaggerated sympathetic nervous system response. Research has shown how 
the direct and indirect effects of both acute and chronic angry emotions 
contribute to atherogenesis and subsequent CHD through increases in blood 
pressure and heart rate (CVR), and inflammatory responses. 
The review of literature for this study reports significant correlations 
between anger, hypertension, CHD, premature death from CHD, and carotid 
atherosclerosis and provide solid evidence for the anger-CVR-CHD connection. 
Research examining immunological relationships and anger are meager and 
were mostly examined within the context of the role of inflammation as a 
precursor to CHD. Cited PNI studies seemed to indicate that anger may affect 
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changes in NK, NKCA, CRP, and some cytokines with an overall negative impact 
on inflammatory and immune responses.  
In general, research to date has been limited by the use of convenience 
samples of primarily male populations and the use of instruments that capture 
more of the constructs of hostility, aggression, or anxiety rather than anger. Very 
few studies related anger control to measureable cytokine levels, with most being 
related to measures of CVR.  
Discussion of Findings 
 The specific aims of this study were to compare differences in serum 
levels of CRP in 45-65 year-old post-menopausal women who were classified as 
either high or low anger trait. Mean CRP levels were not significantly related total 
trait anger scores or total anger expression scores. There were strong and 
positive correlations with waist circumference in that levels of CRP increased as 
waist circumference increased. This linear association has been repeated in 
multiple studies over many years and was not unexpected. The CRP-waist 
circumference relationship replicated in this study is based on the well-known 
role of excessive adipose tissue, particularly visceral fat in the abdominal area, 
as key regulators of inflammation and a major source of pro-inflammatory 
cytokines (Tracy, 2001; Yudkin, Humphries, & Mohamaed-Ali, 2000).  
 CRP levels were significantly inversely related to anger control-in scores; 
as anger control-in scores increased, CRP levels decreased. This same inverse 
relationship was also noted, although not statistically significant, between CRP 
and anger-out scores.   
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 Exactly which components of anger trait and anger expression contribute 
to positive health outcomes have been studied with mixed results (Hogan & 
Linden, 2004; Thomas, 2007). The comparison of this study to previous research 
is limited because only a handful of studies used the STAXI, STAXI-2, and/or 
STAXI-2 subscales applying Spielberger’s (1999) definition of anger control-in 
and anger control-out (see Table 2). As noted earlier, many studies used 
questionnaires that actually measured hostility, anxiety, and negative mood, but 
reported the results as anger trait and anger expression characteristics.  
 This study found that higher anger control, especially anger control-in was 
associated with lower levels of CRP, a marker of inflammation.  Anger control-in 
is anger controlled through suppression, and the induction of calm and relaxation 
at the moment an angry feeling arises. Persons with high anger control-in scores 
tend to focus on calming down and reducing their anger as soon as possible. 
High anger control-out scores indicate that a person spends a great deal of time 
and energy in monitoring their outward expression and experience of anger. This 
finding was consistent with two other studies that measured CRP with the STAXI-
2 reported in this paper (Gouin, et al, 2008; Hapuarachchi, et al.,  2003). 
 Gouin et al. (2008) used the STAXI-2 and found no significant differences 
in wound healing among high and low anger expressers, but did show that higher 
levels of anger control were associated with a higher likelihood of faster healing. 
Anger control predicted healing over and above differences in negative affect, 
social support, and health behaviors. Perhaps anger control creates a beneficial 
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physiological state that ameliorates the effects of stress on the inflammatory 
process. 
 Hapuarachchi et al. (2003) found CRP levels to be significantly lower as 
anger control scores increased although he did not differentiate between anger 
control-in and anger control-out levels. He surmised that the use of productive 
anger coping skills may provide physiological benefit. These findings are similar 
to the results of this study, supporting the idea of health benefits through anger 
control. 
 Although not measuring CRP, Ishihara et al. (2003) observed high values 
of anger control significantly increased NK cell activity in CHD patients, but not in 
normal controls. NK cytotoxic function is affected by positive emotions, in 
general, and is an index of the ability of the immune system to kill viruses, cancer 
cells, and foreign cells (Vedhara & Irwin, 2005). He speculated that this was likely 
an over response related to anger experiences of daily life and was a function of 
the acute neuroendocrine response rather than anger expression style. He 
proposed that frequent exposure to anger provoking events could contribute to 
chronic stress and downregulate the immune response. 
 Lawler et al. (1998) found high anger control correlated with lower levels 
of systolic blood pressure in subjects with a family history of hypertension, and to 
a lesser extent in those without a family history during an anger recall interview. 
These results were attributed to increased awareness of CVR risk related to 
family history and the conscious response to control anger expression styles 
(calming down). 
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 Williams’ et al. (2000) large prospective study revealed that over time, 
healthy high anger trait individuals were three times as likely to be at risk for 
cardiovascular events compared to their low anger trait counterparts. These 
anger-prone persons, by their propensity to experience frequent high anger 
arousal over long periods of time, are particularly likely to suffer 
pathophysiological consequences related to chronic anger mismanagement.  
 As noted, research in this area is sparse, particularly related to measuring 
immune variables in relation to anger control and anger expression styles and 
health outcomes, particularly in women. Even less research has been done on 
measuring these biomarkers after cognitive behavioral interventions have been 
completed. Research on depression has shown a direct relationship between 
depressive emotional states and stress induced immune activation, similar to an 
acute phase response, where downregulation of the NK cell and T-cell-mediated 
response might adversely affect health (Zorilla et al., 2001.)  
Strengths and Limitations 
 A significant limitation to the study was the small sample size (N=42) and 
unequal group sizes. The sample size was lower than the a priori calculation 
requiring 26 women in each group for a total sample size of 52 which would have 
been large enough to allow calculation of a large effect size with a power of 
d=.80. The CRP levels of the sample study were generally low across groups. 
For example, the overall sample mean was 2.74 mg/l. Normal levels are 
considered to be below 3 mg/l with ranges of 0.3 to 6.6 mg/l (Ridker, 2004). 
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 This study consisted of post-menopausal, 45 to 65 year-old women who 
had an average of 16 years of education, were mostly Caucasian and married. 
The results of this study may not be generalizable to men, women of other age 
groups, ethnicity, marital status, or educational level.  
 Because a convenience sample was used and women were offered a 
cash payment to participate, selection bias is possible and may have influenced 
the subjects. The subject questionnaire and the STAXI-2 were both self-report 
measures. Since women knew the purpose of the study they may have 
responded in a manner that would be more likely to include them in the study. 
 Although subjects were excluded if they reported a personal history of 
CHD, diabetes, or other chronic diseases, a detailed health history was not 
obtained and CRP levels may have been affected by the presence or absence of 
unknown conditions that might trigger an inflammatory response.  
Implications for Future Research and Practice 
 Psychosocial factors indirectly and directly affect the risk for and the 
development of CHD. The extent to which anger and other negative emotions 
contribute to sustained CRP production and dysregulation of the immune system 
provides opportunity for early intervention. As women age and the prevalence 
and incidence of women with CHD increases, research that identifies modifiable 
psychosocial risk factors becomes increasingly important and can be examined 
on both biological and psychosocial scales. 
 The theoretical framework of this study was based on the biopsychosocial 
model of mind-body interactions (see Figure 1) and proposed high trait anger and 
high anger expression responses may promote CHD. However, as pointed out by 
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Thomas (2007) not all anger coping styles are unhealthy. Anger-discuss 
describes talking about angry feelings with the provocateur or with a supportive 
close friend. This type of anger control-out, whether a result of personal anger 
coping strategies or anger management intervention strategies has been 
associated with lower blood pressure (Abel et al., 1995; Hogan & Linden, 2004; 
Thomas, 1997) and better glycemic control in diabetic subjects (Yi, Yi, Vitaliano, 
& Weinger, 2008).  
 Given the accumulating evidence from large prospective studies that 
anger influences the development of CHD (Williams et al., 2000), angry 
temperament and exposure to chronic and repeated stressors sustain CVR, and 
affect immune responses (Lovallo & Gerin, 2003), opportunity is created to 
further research these intricate relationships. However, which components of 
anger expression are more likely contribute to adverse health outcomes needs 
further study since not all anger forms of anger expression are necessary 
unhealthy. 
 For example, management of unhealthy anger expression styles might 
contribute to downregulation of pro-inflammatory responses in women with 
chronic diseases could also be evaluated for anger expression styles that may 
negatively influence disease distress. Active anger coping activities (relaxation, 
deep breathing) and cognitive anger management strategies could be taught to 
provide women with positive ways to cope with the daily stressors inherent with 
chronic diseases and minimize the deleterious effects of inflammatory responses 
of acute and chronic stress responses to angry emotions.  
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 In conclusion, measuring PNI responses is a relative new science to 
nursing. The measurement of proinflammatory biomarkers provides objective and 
relatively accurate and precise measurements. Combined with in vivo (CVR) and 
in vitro (cytokines) measurements, subjective dimensions of anger characteristics 
provide opportunity to validate the health risks associated with stressful emotions 
like acute and chronic anger. For example, a prospective study which included 
the contributions of age, genetics, medical history, history of stressors, immune 
activation, socioeconomic status, depression, perceived stress, and daily lifestyle 
habits could examine the effect of stress reduction and positive anger coping 
education on proinflammatory cytokines, including CRP, against anger trait and 
expression scales and subscales over time to partial out the independent and 
deleterious effects of unhealthy anger coping strategies. Repeating these 
measurements following angry behavior modification could provide evidence of 
the positive effects of anger control on heart health. 
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Appendix A 
Women Needed for a Research Study on Anger 
! Women between the ages of 45-65 who are post-menopausal or post-
hysterectomy are needed to be part of a confidential study about the emotion 
of anger and a blood protein called CRP. 
! You will be asked to fill out a survey about how you experience anger. Based 
on your survey score, you may be asked to complete the second part of the 
study, have you waist measured, and provide a small sample of blood 
obtained from your arm. 
! The entire study will take about 30-40 minutes and you will be offered $10 for 
your time if you are eligible to complete both parts of the study. 
! The study will be completed confidentially in a private room. 
 
You would not be eligible to participate in this study if you: 
 
! cannot speak or read English. 
! weigh less than 110 pounds. 
! smoke cigarettes, use drugs, or drink more than 2 alcoholic 
 beverages/day. 
! have a history of heart disease, stroke, diabetes, or autoimmune diseases. 
! taking cholesterol medications, hormones, or steroids. 
! have had major surgery, trauma, infection, or inflammation in the past 90 
 days. 
 
If you would like to take part in this study, please contact Rosalyn Gross 
239-590-7521 (office) or 239-564-2903 (cell) or rgross@fgcu.edu 
 
Permission to conduct this study has been granted by the University of South 
Florida Institutional Review Board and Florida Gulf Coast University 
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Appendix: B 
 
 
 
 
Informed Consent to Participate in Research  
Information to Consider Before Taking Part in this Research Study 
 
Researchers at the University of South Florida (USF) and Florida Gulf Coast 
University (FGCU) study many topics.  To do this, we need the help of people 
who agree to take part in a research study.  This form tells you about this 
research study. 
We are asking you to take part in a research study that is called: 
 
Relationship of Anger Trait and Anger Expression to C-Reactive Protein in Post-
Menopausal Women 
 
The person who is in charge of this research study is Rosalyn Gross, MS, MSN,    
APRN-BC. 
 
The research will be done at FGCU. 
Purpose of the study 
The purpose of this study is to look at the differences in women’s anger and how 
these differences are associated with a certain normal protein found in blood 
called C - reactive protein or CRP. 
Study Procedures 
If you take part in this study, you will be asked to provide confidential personal 
information about your age, race/ethnicity, whether you are married or unmarried, 
and how many years of school you have completed. You will also be asked to 
complete a short 10-item survey. Your score on the survey will be worked out 
and if your score fits into one of two groups, you will then be asked to complete a 
second survey of 32 questions, have your waist measured and provide a small  
 
 
 
 
Rosalyn Gross: Dissertation 
Informed Consent Minimal 
Risk 
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Appendix B (continued) 
amount (5 ml or about 1 teaspoon) of your blood that a licensed nurse will draw 
from a vein in your arm through a sterile needle. The most amount of time you 
will spend for both parts of the study will be no more than 40 minutes. The first 
part of the study will take about 10 minutes; if you are asked to complete the 
second part of the study, it will take an additional 20-30 minutes. You will only 
have to be in the study one time. The study will take place in a private room at 
the Florida Gulf Coast University Student Health Center. There will be no 
audiotaping or videotaping of you or any of the study. 
Alternatives 
You have the alternative to choose not to participate in this research study.  
Benefits 
We don’t know if you will get any benefits by taking part in this study.   
Risks or Discomfort 
There following risks may occur: 
• There may be slight discomfort from having a needle poked through your 
skin and into your vein while having a blood sample taken. There may be 
a small chance that you will have some minor discomfort and/or bruising 
at the place where the blood sample was taken. There may be a rare 
chance that the skin around the area would get infected if it was not kept 
clean immediately after your blood sample was drawn. 
• If you are a person who finds it hard to look at needles, syringes or their 
own blood, you may feel dizzy or light-headed and would need to be 
careful when standing up after the blood sample is drawn. 
Compensation 
We will pay you for the part of the time you volunteer while being in this study. If 
you spend more than 10 minutes in the study you will be offered a $10 cash 
payment. 
Conflict of Interest Statement  
None. 
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Appendix B (continued) 
Confidentiality 
We must keep your study records confidential.   
Information about your study records will be kept confidential and kept secure by the 
researcher by labeling your record with a number and matched to your 
information through an encoded computer database. Nobody other than the 
researcher will have access to your study records. 
However, certain people may need to see your study records. By law, anyone 
who looks at your records must keep them completely confidential. The only 
people who will be allowed to see these records are: 
• The research team, including the Principal Investigator and the licensed 
nurse who draws your blood.  
• Certain government and university people who need to know more about 
the study.  For example, individuals who provide oversight on this study 
may need to look at your records. This is done to make sure that we are 
doing the study in the right way.  They also need to make sure that we are 
protecting your rights and your safety. These include: 
• the University of South Florida Institutional Review Board (IRB) and 
the staff that work for the IRB.  Other individuals who work for USF 
that provide other kinds of oversight may also need to look at your 
records.   
• the Florida Department of Health, people from the Food and Drug 
Administration (FDA), and people from the Department of Health 
and Human Services (DHHS).  
We may publish what we learn from this study.  If we do, we will not let anyone 
know your name.  We will not publish anything else that would let people know 
who you are.   
Voluntary Participation / Withdrawal 
You should only take part in this study if you want to volunteer.  You should not 
feel that there is any pressure to take part in the study, to please the investigator 
or the research staff.  You are free to participate in this research or withdraw at 
any time.  There will be no penalty or loss of benefits you are entitled to receive if 
you stop taking part in this study. Decision to participate or not to participate will 
not affect your student, job, or professional status. 
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Appendix B (continued) 
Questions, concerns, or complaints 
If you have any questions, concerns or complaints about this study, call Rosalyn 
Gross at 239-564-2903. 
If you have questions about your rights, general questions, complaints, or issues 
as a person taking part in this study, call the Division of Research Integrity and 
Compliance of the University of South Florida at (813) 974-9343. 
If you experience an adverse event or unanticipated problem, call Rosalyn Gross 
at 239-564-2903. 
Consent to Take Part in this Research Study 
It is up to you to decide whether you want to take part in this study.  If you want 
to take part, please sign the form, if the following statements are true. 
I freely give my consent to take part in this study.  I understand that by 
signing this form I am agreeing to take part in research.  I have received a copy 
of this form to take with me. 
             
Signature of Person Taking Part in Study    Date 
 
        
Printed Name of Person Taking Part in Study 
Statement of Person Obtaining Informed Consent 
I have carefully explained to the person taking part in the study what he or she 
can expect. 
 
I hereby certify that when this person signs this form, to the best of my 
knowledge, he or she understands: 
• What the study is about. 
• What procedures/interventions/investigational drugs or devices will be 
used. 
• What the potential benefits might be.  
• What the known risks might be.   
 
I also certify that he or she does not have any problems that could make it hard 
to understand what it means to take part in this research.  This person speaks 
the language that was used to explain this research. 
 
This person reads well enough to understand this form or, if not, this person is 
able to hear and understand when the form is read to him or her. 
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Appendix B (continued) 
 
This person does not have a medical/psychological problem that would 
compromise comprehension and therefore makes it hard to understand what is 
being explained and can, therefore, give informed consent.   
 
This person is not taking drugs that may cloud their judgment or make it hard to 
understand what is being explained and can, therefore, give informed consent.   
 
          ____________ 
  
Signature of Person Obtaining Informed Consent   Date   
 
         
Printed Name of Person Obtaining Informed Consent 
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Appendix C: Subject Screening Form 
Are you between the ages of 45-65?     Yes No 
Are you postmenopausal or post hysterectomy?   Yes No 
Do you take hormone replacement therapy (pills/patches)?  Yes No 
Do you take medication to lower your cholesterol?   Yes No 
Do you take prescribed anti-inflammatory medication?  Yes No 
Do you take more than two aspirins daily?    Yes  No 
Do you smoke?       Yes  No 
Do you drink more than two alcoholic beverages daily?  Yes No 
In the past ten (10) days, have you had any minor surgery? Yes No 
In the past ninety (90) days, have you had any of the following? 
 Hospitalization for major trauma, surgery or illness  Yes No 
 Acute infection or inflammation    Yes No 
Do you have or have you had any of the following conditions? 
 Coronary heart disease     Yes No 
 Congestive heart failure     Yes No 
 Cerebral vascular disease or stroke    Yes No 
 Diabetes       Yes No 
 Autoimmune disease (rheumatoid arthritis, lupus, etc.) Yes No 
 Chronic bronchitis      Yes No 
 Chronic renal disease      Yes  No   
 Severe mental disease     Yes No  
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Appendix D:  State Trait Anger Expression Inventory-2 
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